RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (MARKET WIRE) -- March 26, 2007 -- Adherex Technologies Inc. (TSX: AHX)(AMEX: ADH), a biopharmaceutical company with a broad portfolio of oncology products under development, today reported its financial results for the twelve-month fiscal period ended December 31, 2006. All amounts are in U.S. dollars unless otherwise indicated.
